Stock Comparison
ALNY vs ARGX
Alnylam Pharmaceuticals Inc and argenx NV ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$38.90B
$55.44B
P/E (TTM)
73.0
39.4
Forward P/E
31.3
34.0
Price/Sales
9.1
11.7
Price/Book
36.2
7.5
EV/EBITDA
42.9
33.9
Dividend Yield
—
—
Profitability
Net Margin
12.60%
31.40%
Operating Margin
23.00%
30.00%
Return on Equity
90.40%
20.20%
Return on Assets
10.10%
8.86%
Growth (YoY)
Revenue Growth
96.40%
62.60%
Earnings Growth
0.00%
114.00%
Price & Risk
Beta
0.3
-0.0
52-Week High
$495.55
$934.62
52-Week Low
$273.11
$510.06
Analyst Target
$436.32
$1,041.14
Compare ALNY and ARGX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.